Skip to main content
. 2020 Feb 19;13:1557–1560. doi: 10.2147/OTT.S236706

Figure 1.

Figure 1

Primary lung cancer and mediastinal metastases before and after alectinib therapy. Chest computed tomography scan before treatment showed a lung mass in the left upper lobe (A, white arrows) and metastasis (B). After administration of alectinib, the primary tumor size was decreased (C, white arrows); however, the subcarinal lymph node had enlarged despite alectinib therapy (D, white arrows).